The inhibition of ETS1 (avian erythroblastosis virus E26 oncogene homolog-1), a protooncogene transcription factor with a role in glioma development, may be a possible strategy for glioma treatment (Sahin et al., 2005). The gene discussed is ETS1; the disease is central nervous system cancer.